Caspase inhibitors in prevention of apoptosis

Area of Science:

• Cell Biology
• Biochemistry
• Pathology

Background:

• Apoptosis is a fundamental biological process essential for development, homeostasis, and immunity.
• Dysregulation of apoptosis is linked to diseases such as cancer, autoimmune disorders, and viral infections.
• The final stages of apoptosis are highly conserved across cell types, despite diverse initiating signals.

Purpose of the Study:

• To review recent advancements in understanding apoptosis.
• To explore the therapeutic potential of caspase inhibitors for treating diseases associated with apoptotic dysregulation.
• To discuss the development and discovery of synthetic and natural caspase inhibitors.

Main Methods:

• Literature review of recent research on apoptosis and caspases.
• Analysis of studies on synthetic and natural caspase inhibitors.
• Discussion of the mechanisms of caspase activation and inhibition.

Main Results:

• Caspases are key cysteine proteases that execute the conserved final stages of apoptosis.
• Synthetic peptide inhibitors and natural compounds have been identified that target caspase activation or activity.
• These inhibitors demonstrate selectivity for different caspases.

Conclusions:

• Caspase inhibitors represent a promising therapeutic strategy for managing diseases linked to apoptotic dysregulation.
• Further research into selective caspase inhibitors could lead to novel treatments.
• Targeting the conserved execution phase of apoptosis offers a viable therapeutic avenue.